Gherghina, F.-L.; Mîndrilă, I.; Buteică, S.-A.; Bică, G.; Pisoschi, C.-G.; Biță, C.-E.; Paliu, I.-A.; Rogoveanu, O.-C.
The Potential Benefic Effect of Nicotinamide Riboside in Treating a Murine Model of Monoiodoacetate-Induced Knee Osteoarthritis. J. Clin. Med. 2023, 12, 6920.
https://doi.org/10.3390/jcm12216920
AMA Style
Gherghina F-L, Mîndrilă I, Buteică S-A, Bică G, Pisoschi C-G, Biță C-E, Paliu I-A, Rogoveanu O-C.
The Potential Benefic Effect of Nicotinamide Riboside in Treating a Murine Model of Monoiodoacetate-Induced Knee Osteoarthritis. Journal of Clinical Medicine. 2023; 12(21):6920.
https://doi.org/10.3390/jcm12216920
Chicago/Turabian Style
Gherghina, Florin-Liviu, Ion Mîndrilă, Sandra-Alice Buteică, George Bică, Cătălina-Gabriela Pisoschi, Cristina-Elena Biță, Iulia-Alexandra Paliu, and Otilia-Constantina Rogoveanu.
2023. "The Potential Benefic Effect of Nicotinamide Riboside in Treating a Murine Model of Monoiodoacetate-Induced Knee Osteoarthritis" Journal of Clinical Medicine 12, no. 21: 6920.
https://doi.org/10.3390/jcm12216920
APA Style
Gherghina, F.-L., Mîndrilă, I., Buteică, S.-A., Bică, G., Pisoschi, C.-G., Biță, C.-E., Paliu, I.-A., & Rogoveanu, O.-C.
(2023). The Potential Benefic Effect of Nicotinamide Riboside in Treating a Murine Model of Monoiodoacetate-Induced Knee Osteoarthritis. Journal of Clinical Medicine, 12(21), 6920.
https://doi.org/10.3390/jcm12216920
